Common Contracts
12 similar Severance and Change in Control Agreement contracts by Anadys Pharmaceuticals Inc
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • October 25th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENT (the “Agreement”) is made and entered into effective as of August 25, 2011, (the “Effective Date”), by and between ANADYS PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Severance and Change in Control Agreement between Executive and the Company entered into as of (the “Prior Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 4th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of January 24, 2011, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Peter T. Slover (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Severance and Change in Control Agreement between Executive and the Company entered into as of July 1, 2009 (the “Prior Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 4th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of February 6, 2011, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Stephen T. Worland, Ph.D. (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Severance and Change in Control Agreement between Executive and the Company entered into as of March 3, 2008 (the “Prior Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 4th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of January 24, 2011, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Elizabeth E. Reed (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Severance and Change in Control Agreement between Executive and the Company entered into as of March 3, 2008 (the “Prior Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • January 24th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of [ ] (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and [ ] (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain between Executive and the Company entered into as of [ ] (the “Prior Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • January 24th, 2011 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of January 24, 2011, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and James L. Freddo, MD (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. From and following the Effective Date, this Agreement shall replace and supersede that certain Amended and Restated Severance and Change in Control Agreement between Executive and the Company entered into as of March 3, 2008 (the “Prior Agreement”).
SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • July 31st, 2009 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of July 1, 2009, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Peter T. Slover (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Change in Control Agreement between Executive (then a senior employee) and the Company entered into as of March 4, 2008 (the “Original Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 5th, 2008 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of March 3, 2008, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Mary Yaroshevsky-Glanville (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Severance Agreement between Executive and the Company entered into as of November 14, 2003 (the “Original Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 5th, 2008 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of March 3, 2008, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and James L. Freddo, MD (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Change in Control Agreement between Executive and the Company entered into as of November 1, 2006 (the “Original Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 5th, 2008 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of March 3, 2008, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Elizabeth E. Reed (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Severance Agreement between Executive and the Company entered into as of November 14, 2003 (the “Original Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 5th, 2008 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of March 3, 2008, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Stephen T. Worland, Ph.D. (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Severance Agreement between Executive and the Company entered into as of November 14, 2003 (the “Original Agreement”).
AMENDED AND RESTATED SEVERANCE AND CHANGE IN CONTROL AGREEMENTSeverance and Change in Control Agreement • March 5th, 2008 • Anadys Pharmaceuticals Inc • Pharmaceutical preparations • California
This Amended and Restated Severance and Change in Control Agreement (the “Agreement”) is made and entered into effective as of March 3, 2008, (the “Effective Date”), by and between Anadys Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and James T. Glover (the “Executive”). The Company and the Executive are hereinafter collectively referred to as the “Parties”, and individually referred to as a “Party”. This Agreement shall replace and supersede that certain Severance and Change in Control Agreement between Executive and the Company entered into as of November 13, 2006 (the “Original Agreement”).
